K. Odagiri

GNRI Sustainability during One Cycle of First-Line Chemotherapy as a Prognostic Indicator in Patients with Metastatic Urothelial Carcinoma

T. Naiki, S. Nozaki, T. Nagai, 2023, Oncology.

Eosinophil may be a predictor of immune‐related adverse events induced by different immune checkpoint inhibitor types: A retrospective multidisciplinary study

T. Naiki, H. Komatsu, T. Shimura, 2023, Cancer medicine.

Hemoglobin and neutrophil levels stratified according to International Metastatic Renal Cell Carcinoma Database Consortium risk predict the effectiveness of ipilimumab plus nivolumab in patients with advanced metastatic renal cell carcinoma

Yoko Furukawa-Hibi, T. Naiki, T. Etani, 2023, International journal of urology : official journal of the Japanese Urological Association.